25 XP   0   0   10

Spruce Biosciences Inc
Buy, Hold or Sell?

Let's analyse Spruce Biosciences Inc together

PenkeI guess you are interested in Spruce Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Spruce Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Spruce Biosciences Inc

I send you an email if I find something interesting about Spruce Biosciences Inc.

Quick analysis of Spruce Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Spruce Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
17.6%

What is your share worth?

Current worth
$1.86
Expected worth in 1 year
$2.05
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$0.20
Return On Investment
27.8%

For what price can you sell your share?

Current Price per Share
$0.71
Expected price per share
$0.6786 - $0.962
How sure are you?
50%

1. Valuation of Spruce Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.71

Intrinsic Value Per Share

$-8.93 - $-10.37

Total Value Per Share

$-7.07 - $-8.51

2. Growth of Spruce Biosciences Inc (5 min.)




Is Spruce Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$76.5m$84m$7.5m8.2%

How much money is Spruce Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$11.9m-$11.2m-$636.7k-5.3%
Net Profit Margin-494.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Spruce Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#425 / 1019

Most Revenue
#424 / 1019

Most Profit
#583 / 1019

Most Efficient
#748 / 1019

What can you expect buying and holding a share of Spruce Biosciences Inc? (5 min.)

Welcome investor! Spruce Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Spruce Biosciences Inc.

What can you expect buying and holding a share of Spruce Biosciences Inc?

First you should know what it really means to hold a share of Spruce Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Spruce Biosciences Inc is $0.7062. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Spruce Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Spruce Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.86. Based on the TTM, the Book Value Change Per Share is $0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Spruce Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.24-34.2%-0.29-41.2%-0.28-39.7%-0.24-34.1%-0.24-34.1%
Usd Book Value Change Per Share-0.22-30.5%0.056.9%-0.26-36.9%0.1115.5%0.1115.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.011.1%0.011.1%
Usd Total Gains Per Share-0.22-30.5%0.056.9%-0.26-36.9%0.1216.6%0.1216.6%
Usd Price Per Share2.93-2.39-1.55-4.61-4.61-
Price to Earnings Ratio-3.03--2.10--1.38--4.79--4.79-
Price-to-Total Gains Ratio-13.59--6.84--5.92--19.28--19.28-
Price to Book Ratio1.58-1.11-0.75-1.54-1.54-
Price-to-Total Gains Ratio-13.59--6.84--5.92--19.28--19.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7062
Number of shares1416
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.050.11
Usd Total Gains Per Share0.050.12
Gains per Quarter (1416 shares)69.44165.55
Gains per Year (1416 shares)277.77662.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1227626843619652
235525468512391314
3582882412818581976
471104110217124782638
581380138021430973300
6101656165825637173962
7121933193629943364624
8132209221434249565286
9152485249238555755948
10172761277042761956610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.013.01.017.6%3.013.01.017.6%3.013.01.017.6%
Dividend per Share2.00.02.050.0%3.00.09.025.0%3.00.014.017.6%3.00.014.017.6%3.00.014.017.6%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.013.01.017.6%3.013.01.017.6%3.013.01.017.6%

Fundamentals of Spruce Biosciences Inc

About Spruce Biosciences Inc

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-12 18:59:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Spruce Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Spruce Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -344.6% means that $-3.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Spruce Biosciences Inc:

  • The MRQ is -344.6%. The company is making a huge loss. -2
  • The TTM is -494.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-344.6%TTM-494.0%+149.4%
TTM-494.0%YOY--494.0%
TTM-494.0%5Y-116.2%-377.8%
5Y-116.2%10Y-116.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-344.6%-197.2%-147.4%
TTM-494.0%-210.4%-283.6%
YOY--279.3%+279.3%
5Y-116.2%-436.8%+320.6%
10Y-116.2%-599.3%+483.1%
1.1.2. Return on Assets

Shows how efficient Spruce Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • -9.6% Return on Assets means that Spruce Biosciences Inc generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Spruce Biosciences Inc:

  • The MRQ is -9.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-9.9%+0.3%
TTM-9.9%YOY-11.3%+1.4%
TTM-9.9%5Y-19.2%+9.3%
5Y-19.2%10Y-19.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-13.6%+4.0%
TTM-9.9%-12.9%+3.0%
YOY-11.3%-11.9%+0.6%
5Y-19.2%-14.2%-5.0%
10Y-19.2%-16.2%-3.0%
1.1.3. Return on Equity

Shows how efficient Spruce Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • -13.0% Return on Equity means Spruce Biosciences Inc generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Spruce Biosciences Inc:

  • The MRQ is -13.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.0%TTM-13.1%+0.1%
TTM-13.1%YOY-13.6%+0.5%
TTM-13.1%5Y-9.9%-3.2%
5Y-9.9%10Y-9.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.0%-17.0%+4.0%
TTM-13.1%-16.1%+3.0%
YOY-13.6%-15.4%+1.8%
5Y-9.9%-20.0%+10.1%
10Y-9.9%-21.1%+11.2%

1.2. Operating Efficiency of Spruce Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Spruce Biosciences Inc is operating .

  • Measures how much profit Spruce Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -386.7% means the company generated $-3.87  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Spruce Biosciences Inc:

  • The MRQ is -386.7%. The company is operating very inefficient. -2
  • The TTM is -522.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-386.7%TTM-522.8%+136.1%
TTM-522.8%YOY--522.8%
TTM-522.8%5Y-123.0%-399.8%
5Y-123.0%10Y-123.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-386.7%-286.1%-100.6%
TTM-522.8%-224.4%-298.4%
YOY--288.4%+288.4%
5Y-123.0%-475.2%+352.2%
10Y-123.0%-624.7%+501.7%
1.2.2. Operating Ratio

Measures how efficient Spruce Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.87 means that the operating costs are $4.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Spruce Biosciences Inc:

  • The MRQ is 4.867. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.391. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.867TTM6.391-1.524
TTM6.391YOY-+6.391
TTM6.3915Y1.504+4.887
5Y1.50410Y1.5040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8672.997+1.870
TTM6.3913.247+3.144
YOY-3.766-3.766
5Y1.5045.675-4.171
10Y1.5047.857-6.353

1.3. Liquidity of Spruce Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Spruce Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.18 means the company has $4.18 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Spruce Biosciences Inc:

  • The MRQ is 4.177. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.050. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.177TTM5.050-0.873
TTM5.050YOY8.659-3.610
TTM5.0505Y8.859-3.809
5Y8.85910Y8.8590.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1773.930+0.247
TTM5.0504.251+0.799
YOY8.6595.436+3.223
5Y8.8596.045+2.814
10Y8.8596.363+2.496
1.3.2. Quick Ratio

Measures if Spruce Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.94 means the company can pay off $3.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Spruce Biosciences Inc:

  • The MRQ is 3.938. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.713. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.938TTM5.713-1.775
TTM5.713YOY13.891-8.178
TTM5.7135Y10.548-4.835
5Y10.54810Y10.5480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9383.629+0.309
TTM5.7134.065+1.648
YOY13.8915.397+8.494
5Y10.5485.993+4.555
10Y10.5486.277+4.271

1.4. Solvency of Spruce Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Spruce Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Spruce Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.26 means that Spruce Biosciences Inc assets are financed with 26.4% credit (debt) and the remaining percentage (100% - 26.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Spruce Biosciences Inc:

  • The MRQ is 0.264. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.241. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.264TTM0.241+0.023
TTM0.241YOY0.163+0.078
TTM0.2415Y1.122-0.881
5Y1.12210Y1.1220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2640.332-0.068
TTM0.2410.334-0.093
YOY0.1630.268-0.105
5Y1.1220.366+0.756
10Y1.1220.390+0.732
1.4.2. Debt to Equity Ratio

Measures if Spruce Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 35.9% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Spruce Biosciences Inc:

  • The MRQ is 0.359. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.319. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.359TTM0.319+0.040
TTM0.319YOY0.196+0.122
TTM0.3195Y0.173+0.146
5Y0.17310Y0.1730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3590.381-0.022
TTM0.3190.390-0.071
YOY0.1960.334-0.138
5Y0.1730.434-0.261
10Y0.1730.466-0.293

2. Market Valuation of Spruce Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Spruce Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Spruce Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -3.03 means the investor is paying $-3.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Spruce Biosciences Inc:

  • The EOD is -0.730. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.029. Based on the earnings, the company is expensive. -2
  • The TTM is -2.103. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.730MRQ-3.029+2.299
MRQ-3.029TTM-2.103-0.926
TTM-2.103YOY-1.379-0.725
TTM-2.1035Y-4.787+2.684
5Y-4.78710Y-4.7870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.730-2.315+1.585
MRQ-3.029-2.560-0.469
TTM-2.103-2.664+0.561
YOY-1.379-4.122+2.743
5Y-4.787-6.258+1.471
10Y-4.787-6.108+1.321
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Spruce Biosciences Inc:

  • The EOD is -0.648. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.689. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.147. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.648MRQ-2.689+2.041
MRQ-2.689TTM1.147-3.836
TTM1.147YOY-1.557+2.703
TTM1.1475Y-4.270+5.417
5Y-4.27010Y-4.2700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.648-3.067+2.419
MRQ-2.689-3.251+0.562
TTM1.147-3.545+4.692
YOY-1.557-5.595+4.038
5Y-4.270-8.315+4.045
10Y-4.270-8.708+4.438
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Spruce Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.58 means the investor is paying $1.58 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Spruce Biosciences Inc:

  • The EOD is 0.380. Based on the equity, the company is cheap. +2
  • The MRQ is 1.576. Based on the equity, the company is underpriced. +1
  • The TTM is 1.106. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.380MRQ1.576-1.196
MRQ1.576TTM1.106+0.470
TTM1.106YOY0.751+0.354
TTM1.1065Y1.543-0.438
5Y1.54310Y1.5430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3801.905-1.525
MRQ1.5762.111-0.535
TTM1.1062.095-0.989
YOY0.7512.836-2.085
5Y1.5433.443-1.900
10Y1.5433.794-2.251
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Spruce Biosciences Inc.

3.1. Institutions holding Spruce Biosciences Inc

Institutions are holding 72.499% of the shares of Spruce Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Novo A/S16.51251.2163672233600
2023-12-31RiverVest Venture Management LLC7.212631.7239293628100
2023-12-31The Carlyle Group Inc7.11490.4026289651800
2023-12-31Rock Springs Capital Management LP6.40890.18822609125-119000-4.362
2023-12-315AM Venture Management, LLC5.80681.8374236400000
2023-12-31Armistice Capital, LLC5.47770.08922230000-826000-27.0288
2023-09-30Omega Fund Management LLC5.30824.4858216102200
2023-12-31AIGH Capital Management, LLC5.2172.4619212386391286375.3809
2023-12-31Aisling Capital Management LP2.96121.0536120551100
2023-09-30Alyeska Investment Group, L.P.2.45640.0154100000000
2023-12-31Vanguard Group Inc2.02010.0001822390494121150.5232
2023-12-31Sands Capital Ventures, LLC1.93320.641578700700
2023-12-31Dafna Capital Management LLC1.34730.3851548510-21620-3.7921
2023-12-31Worth Venture Partners, LLC1.29430.834452693322485974.4384
2023-12-31Millennium Management LLC1.25380.0007510441-73031-12.5166
2023-12-31Acuitas Investments, LLC0.67570.4209275085840.0305
2023-12-31BlackRock Inc0.6411026101625150.9729
2023-12-31Renaissance Technologies Corp0.45470.0008185100-22676-10.9137
2023-12-31Geode Capital Management, LLC0.41120.000116740400
2023-12-31Two Sigma Investments LLC0.330.0009134357-13000-8.8221
Total 74.837645.758830466899+559115+1.8%

3.2. Funds holding Spruce Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.55630.000263855800
2024-02-29Janus Henderson Hrzn Biotec E2 USD1.43121.11985872055872050
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.45230.000918556617340.9433
2024-02-29EAM Ultra Micro Cap0.29190.70631197471197470
2024-02-29Fidelity Extended Market Index0.24960.0013102406-496-0.482
2023-12-31Bridgeway Ultra-Small Company Market0.20720.1348500000
2023-09-30BlackRock Extended Mkt Composite0.17820.00127309600
2024-03-28iShares Micro-Cap ETF0.13890.00495698600
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0810.00153324100
2024-02-29Fidelity Total Market Index0.07680.00023150300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06510.001626697500.1876
2024-02-29Fidelity Series Total Market Index0.05850.00022400800
2024-02-29Fidelity Nasdaq Composite Index0.04930.00072021900
2024-02-29Schwab Total Stock Market Index0.03730.00031528900
2024-02-29Spartan Total Market Index Pool E0.03560.00021461000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.03230.00071327100
2023-12-31Northern Trust Extended Eq Market Idx0.03230.00071327100
2024-03-29Avantis US Small Cap Equity ETF0.01980.0006810800
2024-02-29Vanguard U.S. Eq Idx £ Acc0.01970.0002809980990
2024-03-29Dimensional US Small Cap ETF0.01690.0001692600
Total 5.03021.97562063806+716339+34.7%

3.3. Insider Transactions

Insiders are holding 0.888% of the shares of Spruce Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-20Holdings A/s NovoSELL3599790.73
2024-03-18Holdings A/s NovoSELL8420200.77
2024-03-14Holdings A/s NovoSELL19123160.89

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Spruce Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2160.049-542%-0.261+21%0.109-297%0.109-297%
Book Value Per Share--1.8592.226-16%2.043-9%1.817+2%1.817+2%
Current Ratio--4.1775.050-17%8.659-52%8.859-53%8.859-53%
Debt To Asset Ratio--0.2640.241+9%0.163+62%1.122-76%1.122-76%
Debt To Equity Ratio--0.3590.319+13%0.196+83%0.173+107%0.173+107%
Dividend Per Share---0.000-100%-0%0.008-100%0.008-100%
Eps---0.242-0.291+20%-0.281+16%-0.2410%-0.2410%
Free Cash Flow Per Share---0.272-0.202-26%-0.253-7%-0.202-26%-0.202-26%
Free Cash Flow To Equity Per Share---0.2860.096-397%-0.255-11%0.130-319%0.130-319%
Gross Profit Margin--1.0021.000+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---10.369--------
Intrinsic Value_10Y_min---8.934--------
Intrinsic Value_1Y_max---0.920--------
Intrinsic Value_1Y_min---0.904--------
Intrinsic Value_3Y_max---2.856--------
Intrinsic Value_3Y_min---2.724--------
Intrinsic Value_5Y_max---4.900--------
Intrinsic Value_5Y_min---4.540--------
Market Cap29059565.040-315%120567156.00098243715.000+23%63956144.100+89%189666344.965-36%189666344.965-36%
Net Profit Margin---3.446-4.940+43%--100%-1.162-66%-1.162-66%
Operating Margin---3.867-5.228+35%--100%-1.230-68%-1.230-68%
Operating Ratio--4.8676.391-24%-+100%1.504+224%1.504+224%
Pb Ratio0.380-315%1.5761.106+43%0.751+110%1.543+2%1.543+2%
Pe Ratio-0.730+76%-3.029-2.103-31%-1.379-54%-4.787+58%-4.787+58%
Price Per Share0.706-315%2.9302.388+23%1.554+89%4.609-36%4.609-36%
Price To Free Cash Flow Ratio-0.648+76%-2.6891.147-335%-1.557-42%-4.270+59%-4.270+59%
Price To Total Gains Ratio-3.275+76%-13.590-6.840-50%-5.921-56%-19.279+42%-19.279+42%
Quick Ratio--3.9385.713-31%13.891-72%10.548-63%10.548-63%
Return On Assets---0.096-0.099+4%-0.113+18%-0.192+101%-0.192+101%
Return On Equity---0.130-0.131+1%-0.136+4%-0.099-24%-0.099-24%
Total Gains Per Share---0.2160.049-540%-0.261+21%0.117-284%0.117-284%
Usd Book Value--76509000.00091612000.000-16%84081250.000-9%74750058.824+2%74750058.824+2%
Usd Book Value Change Per Share---0.2160.049-542%-0.261+21%0.109-297%0.109-297%
Usd Book Value Per Share--1.8592.226-16%2.043-9%1.817+2%1.817+2%
Usd Dividend Per Share---0.000-100%-0%0.008-100%0.008-100%
Usd Eps---0.242-0.291+20%-0.281+16%-0.2410%-0.2410%
Usd Free Cash Flow---11209000.000-8320500.000-26%-10424250.000-7%-8320588.235-26%-8320588.235-26%
Usd Free Cash Flow Per Share---0.272-0.202-26%-0.253-7%-0.202-26%-0.202-26%
Usd Free Cash Flow To Equity Per Share---0.2860.096-397%-0.255-11%0.130-319%0.130-319%
Usd Market Cap29059565.040-315%120567156.00098243715.000+23%63956144.100+89%189666344.965-36%189666344.965-36%
Usd Price Per Share0.706-315%2.9302.388+23%1.554+89%4.609-36%4.609-36%
Usd Profit---9950000.000-11910500.000+20%-11273750.000+13%-9867647.059-1%-9867647.059-1%
Usd Revenue--2887000.0002522250.000+14%-+100%593470.588+386%593470.588+386%
Usd Total Gains Per Share---0.2160.049-540%-0.261+21%0.117-284%0.117-284%
 EOD+3 -5MRQTTM+15 -21YOY+16 -185Y+9 -2710Y+9 -27

4.2. Fundamental Score

Let's check the fundamental score of Spruce Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.730
Price to Book Ratio (EOD)Between0-10.380
Net Profit Margin (MRQ)Greater than0-3.446
Operating Margin (MRQ)Greater than0-3.867
Quick Ratio (MRQ)Greater than13.938
Current Ratio (MRQ)Greater than14.177
Debt to Asset Ratio (MRQ)Less than10.264
Debt to Equity Ratio (MRQ)Less than10.359
Return on Equity (MRQ)Greater than0.15-0.130
Return on Assets (MRQ)Greater than0.05-0.096
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Spruce Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.954
Ma 20Greater thanMa 500.763
Ma 50Greater thanMa 1002.942
Ma 100Greater thanMa 2002.628
OpenGreater thanClose0.693
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets103,946
Total Liabilities27,437
Total Stockholder Equity76,509
 As reported
Total Liabilities 27,437
Total Stockholder Equity+ 76,509
Total Assets = 103,946

Assets

Total Assets103,946
Total Current Assets102,183
Long-term Assets1,763
Total Current Assets
Cash And Cash Equivalents 96,339
Other Current Assets 5,844
Total Current Assets  (as reported)102,183
Total Current Assets  (calculated)102,183
+/-0
Long-term Assets
Property Plant Equipment 1,181
Long-term Assets Other 547
Long-term Assets  (as reported)1,763
Long-term Assets  (calculated)1,728
+/- 35

Liabilities & Shareholders' Equity

Total Current Liabilities24,465
Long-term Liabilities2,972
Total Stockholder Equity76,509
Total Current Liabilities
Short-term Debt 1,873
Short Long Term Debt 1,622
Accounts payable 3,332
Other Current Liabilities 14,349
Total Current Liabilities  (as reported)24,465
Total Current Liabilities  (calculated)21,176
+/- 3,289
Long-term Liabilities
Long term Debt 1,717
Capital Lease Obligations 1,270
Long-term Liabilities Other 236
Long-term Liabilities  (as reported)2,972
Long-term Liabilities  (calculated)3,223
+/- 251
Total Stockholder Equity
Common Stock4
Retained Earnings -197,232
Other Stockholders Equity 273,737
Total Stockholder Equity (as reported)76,509
Total Stockholder Equity (calculated)76,509
+/-0
Other
Capital Stock4
Cash and Short Term Investments 96,339
Common Stock Shares Outstanding 41,030
Current Deferred Revenue4,911
Liabilities and Stockholders Equity 103,946
Net Debt -91,730
Net Invested Capital 79,848
Net Working Capital 77,718
Property Plant and Equipment Gross 1,181
Short Long Term Debt Total 4,609



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-03-31
> Total Assets 
0
0
4,692
0
38,968
78,485
162,883
153,991
143,448
135,087
126,486
114,988
104,515
95,298
85,648
139,114
125,962
112,985
103,946
103,946112,985125,962139,11485,64895,298104,515114,988126,486135,087143,448153,991162,88378,48538,96804,69200
   > Total Current Assets 
0
0
4,652
38,478
38,478
73,600
160,397
151,586
111,369
93,922
91,895
95,096
96,506
93,186
83,608
137,236
124,129
111,138
102,183
102,183111,138124,129137,23683,60893,18696,50695,09691,89593,922111,369151,586160,39773,60038,47838,4784,65200
       Cash And Cash Equivalents 
0
0
3,924
0
36,601
72,158
157,150
148,627
78,278
58,363
42,748
23,343
47,210
21,649
24,487
73,926
97,482
98,801
96,339
96,33998,80197,48273,92624,48721,64947,21023,34342,74858,36378,278148,627157,15072,15836,60103,92400
       Short-term Investments 
0
0
0
0
0
0
0
0
30,945
33,957
46,221
68,005
46,085
68,751
54,590
44,659
23,041
9,231
0
09,23123,04144,65954,59068,75146,08568,00546,22133,95730,94500000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,000
0
0
0
00015,000000000000000000
       Other Current Assets 
0
0
513
569
569
209
276
272
347
301
396
325
390
2,786
1,211
253
206
419
5,844
5,8444192062531,2112,78639032539630134727227620956956951300
   > Long-term Assets 
0
0
40
0
490
4,885
2,486
2,405
32,079
41,165
34,591
19,892
8,009
2,112
2,040
1,878
1,833
1,847
1,763
1,7631,8471,8331,8782,0402,1128,00919,89234,59141,16532,0792,4052,4864,88549004000
       Property Plant Equipment 
0
0
0
0
0
1,869
1,793
1,716
1,638
1,559
1,479
1,397
1,314
1,229
1,400
1,353
1,297
1,240
1,181
1,1811,2401,2971,3531,4001,2291,3141,3971,4791,5591,6381,7161,7931,86900000
       Long Term Investments 
0
0
0
0
0
0
0
0
29,768
38,975
32,459
17,601
5,805
0
0
0
0
0
0
0000005,80517,60132,45938,97529,76800000000
       Other Assets 
0
0
0
490
490
3,016
2,486
689
673
631
34,591
763
890
883
640
0
536
0
0
00536064088389076334,5916316736892,4863,016490490000
> Total Liabilities 
0
0
35,329
0
9,622
129,926
13,456
13,268
13,342
15,367
15,115
14,745
15,394
16,823
17,162
31,117
29,401
27,604
27,437
27,43727,60429,40131,11717,16216,82315,39414,74515,11515,36713,34213,26813,456129,9269,622035,32900
   > Total Current Liabilities 
0
0
4,303
6,335
6,335
10,086
9,763
6,851
6,980
9,061
8,871
8,969
10,102
12,001
12,447
22,995
22,734
24,188
24,465
24,46524,18822,73422,99512,44712,00110,1028,9698,8719,0616,9806,8519,76310,0866,3356,3354,30300
       Short-term Debt 
0
0
1,252
0
1,263
1,908
2,554
332
341
350
360
775
1,191
1,606
1,761
1,622
1,622
1,866
1,873
1,8731,8661,6221,6221,7611,6061,1917753603503413322,5541,9081,26301,25200
       Short Long Term Debt 
0
0
1,252
0
1,263
1,908
2,554
0
0
0
0
405
811
1,216
1,622
1,622
1,622
1,622
1,622
1,6221,6221,6221,6221,6221,21681140500002,5541,9081,26301,25200
       Accounts payable 
0
0
1,878
2,656
2,656
4,002
3,628
2,566
1,113
2,128
2,823
1,109
1,445
2,181
1,426
3,448
945
3,152
3,332
3,3323,1529453,4481,4262,1811,4451,1092,8232,1281,1132,5663,6284,0022,6562,6561,87800
       Other Current Liabilities 
0
0
1,173
0
2,416
4,176
3,581
3,953
5,526
5,545
6,048
7,085
7,466
8,214
9,260
8,720
12,107
11,372
14,349
14,34911,37212,1078,7209,2608,2147,4667,0856,0485,5455,5263,9533,5814,1762,41601,17300
   > Long-term Liabilities 
0
0
31,026
0
3,287
119,840
3,693
6,417
6,362
6,306
6,244
5,776
5,292
4,822
4,715
8,122
6,667
3,416
2,972
2,9723,4166,6678,1224,7154,8225,2925,7766,2446,3066,3626,4173,693119,8403,287031,02600
       Long term Debt Total 
0
0
0
0
0
0
1,922
4,843
4,855
0
0
0
0
0
3,293
2,901
2,507
0
0
002,5072,9013,293000004,8554,8431,922000000
       Other Liabilities 
0
0
0
87
87
95
118
8
29
51
73
95
117
139
161
0
3,013
0
0
003,0130161139117957351298118958787000
       Deferred Long Term Liability 
0
0
0
200
200
2,347
0
0
0
0
0
0
0
0
0
3,831
2,811
0
0
002,8113,8310000000002,347200200000
> Total Stockholder Equity
0
0
-30,637
0
29,346
-51,441
149,427
140,723
130,106
119,720
111,371
100,243
89,121
78,475
68,486
107,997
96,561
85,381
76,509
76,50985,38196,561107,99768,48678,47589,121100,243111,371119,720130,106140,723149,427-51,44129,3460-30,63700
   Common Stock
0
0
1
1
1
1
2
2
3
3
3
3
3
3
3
4
4
4
4
4444333333322111100
   Retained Earnings Total Equity00-174,928-162,104-149,31300000-82,502-70,728-60,841000000
   Accumulated Other Comprehensive Income 0-3-55-188-558-873-845-693-184-16-2900-27,81300000
   Capital Surplus 
0
0
0
0
0
0
210,266
211,449
212,634
0
0
0
0
0
218,354
270,285
271,540
0
0
00271,540270,285218,35400000212,634211,449210,266000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
664
0
72,261
1,061
210,266
211,449
212,634
213,682
214,685
215,828
216,731
217,514
218,354
270,285
271,540
272,662
273,737
273,737272,662271,540270,285218,354217,514216,731215,828214,685213,682212,634211,449210,2661,06172,261066400



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue10,089
Cost of Revenue-70
Gross Profit10,01910,019
 
Operating Income (+$)
Gross Profit10,019
Operating Expense-62,012
Operating Income-51,993-51,993
 
Operating Expense (+$)
Research Development49,432
Selling General Administrative12,650
Selling And Marketing Expenses70
Operating Expense62,01262,152
 
Net Interest Income (+$)
Interest Income4,332
Interest Expense-483
Other Finance Cost-23
Net Interest Income3,826
 
Pretax Income (+$)
Operating Income-51,993
Net Interest Income3,826
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-47,919-56,067
EBIT - interestExpense = -52,476
-47,919
-47,436
Interest Expense483
Earnings Before Interest and Taxes (EBIT)-51,993-47,436
Earnings Before Interest and Taxes (EBITDA)-51,923
 
After tax Income (+$)
Income Before Tax-47,919
Tax Provision-0
Net Income From Continuing Ops-49,113-47,919
Net Income-47,919
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses62,082
Total Other Income/Expenses Net4,074-3,826
 

Technical Analysis of Spruce Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Spruce Biosciences Inc. The general trend of Spruce Biosciences Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Spruce Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Spruce Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.8698 < 0.955 < 0.962.

The bearish price targets are: 0.6786.

Tweet this
Spruce Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Spruce Biosciences Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Spruce Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Spruce Biosciences Inc. The current macd is -0.56849367.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Spruce Biosciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Spruce Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Spruce Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Spruce Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartSpruce Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Spruce Biosciences Inc. The current adx is 50.87.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Spruce Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Spruce Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Spruce Biosciences Inc. The current sar is 1.28101414.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Spruce Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Spruce Biosciences Inc. The current rsi is 23.95. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Spruce Biosciences Inc Daily Relative Strength Index (RSI) ChartSpruce Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Spruce Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Spruce Biosciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Spruce Biosciences Inc Daily Stochastic Oscillator ChartSpruce Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Spruce Biosciences Inc. The current cci is -86.08897179.

Spruce Biosciences Inc Daily Commodity Channel Index (CCI) ChartSpruce Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Spruce Biosciences Inc. The current cmo is -59.2803632.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Spruce Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartSpruce Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Spruce Biosciences Inc. The current willr is -87.67416935.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Spruce Biosciences Inc Daily Williams %R ChartSpruce Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Spruce Biosciences Inc.

Spruce Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Spruce Biosciences Inc. The current atr is 0.18069568.

Spruce Biosciences Inc Daily Average True Range (ATR) ChartSpruce Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Spruce Biosciences Inc. The current obv is 54,314,863.

Spruce Biosciences Inc Daily On-Balance Volume (OBV) ChartSpruce Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Spruce Biosciences Inc. The current mfi is 61.94.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Spruce Biosciences Inc Daily Money Flow Index (MFI) ChartSpruce Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Spruce Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Spruce Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Spruce Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.954
Ma 20Greater thanMa 500.763
Ma 50Greater thanMa 1002.942
Ma 100Greater thanMa 2002.628
OpenGreater thanClose0.693
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Spruce Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Spruce Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Spruce Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Spruce Biosciences Inc

I send you an email if I find something interesting about Spruce Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Spruce Biosciences Inc.

Receive notifications about Spruce Biosciences Inc in your mailbox!